Abstract
Ceftobiprole is an advanced-generation broad-spectrum cephalosporin antibiotic with potent and rapid bactericidal activity against Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus, as well as susceptible Gram-negative pathogens, including Pseudomonas sp. pathogens. In the case of Pseudomonas aeruginosa, ceftobiprole acts by inhibiting P. aeruginosa penicillin-binding protein 3 (PBP3). Structural studies were pursued to elucidate the molecular details of this PBP inhibition. The crystal structure of the His-tagged PBP3-ceftobiprole complex revealed a covalent bond between the ligand and the catalytic residue S294. Ceftobiprole binding leads to large active site changes near binding sites for the pyrrolidinone and pyrrolidine rings. The S528 to L536 region adopts a conformation previously not observed in PBP3, including partial unwinding of the α11 helix. These molecular insights can lead to a deeper understanding of β-lactam-PBP interactions that result in major changes in protein structure, as well as suggesting how to fine-tune current inhibitors and to develop novel inhibitors of this PBP.
References
Feb 12, 1985·Biochemistry·W S Faraci, R F Pratt
Feb 14, 1971·Journal of Molecular Biology·B Lee, F M Richards
Apr 15, 2000·The Journal of Biological Chemistry·T J FiedlerR E Fenna
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·P HebeisenR L Then
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
May 2, 2007·Antimicrobial Agents and Chemotherapy·Todd A DaviesKaren Bush
Dec 8, 2010·Proceedings of the National Academy of Sciences of the United States of America·Seungil HanVeerabahu Shanmugasundaram
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·Garib N MurshudovAlexei A Vagin
Jul 21, 2012·The Journal of Biological Chemistry·Andrew L LoveringNatalie C J Strynadka
Aug 16, 2012·Bioorganic & Medicinal Chemistry Letters·Mark J Mitton-FryJennifer A Young
Apr 4, 2014·Journal of Medicinal Chemistry·Jeremy StarrSeungil Han
May 26, 2015·ACS Medicinal Chemistry Letters·Kerry E Murphy-BenenatoShannon X Zhao
Jan 30, 2016·FEBS Letters·Jingshan RenRaymond J Owens
Nov 9, 2016·Antimicrobial Agents and Chemotherapy·Wei ChenChristopher Davies
Oct 28, 2018·The Journal of Biological Chemistry·J Andrew N AlexanderNatalie C J Strynadka
Oct 31, 2018·Antimicrobial Agents and Chemotherapy·Michael A PfallerHelio S Sader
Nov 6, 2018·Methods in Enzymology·Christian Bergsdorf, S Kirk Wright
Dec 1, 2018·Biotechnology Advances·Zheng PangZhenyu Cheng
Feb 28, 2019·Diagnostic Microbiology and Infectious Disease·Michael A PfallerHelio S Sader
Citations
Feb 9, 2021·Expert Review of Anti-infective Therapy·Sean N AvedissianJennifer Le
Feb 18, 2021·MBio·Malligarjunan RajavelFocco van den Akker
Mar 7, 2021·International Journal of Molecular Sciences·Lukas HofmannSharon Ruthstein
Oct 16, 2021·PloS One·Vijay KumarFocco van den Akker